Learnings from real-life experience of using omalizumab for chronic urticaria in Latin America

BACKGROUND: Updated urticaria guidelines recommend that patients should be assessed for disease activity, severity, control, and quality of life at baseline and follow up. Regarding treatment, guidelines consider second generation antihistamines as the cornerstone in therapy for chronic urticaria (C...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:World Allergy Organ J
Main Authors: Cherrez-Ojeda, Ivan, Maurer, Marcus, Bernstein, Jonathan A., Vanegas, Emanuel, Felix, Miguel, Ramon, German D., Ensina, Luis Felipe, Larco Sousa, José Ignacio, Matos Benavides, Edgar Emilio, Cardona Villa, R., Latour Staffeld, P., Morfin-Maciel, Blanca María, Mori, Jose, Wilches C, Paul, Mata, Valeria L., Cherrez, Annia
Formato: Artigo
Idioma:Inglês
Publicado em: World Allergy Organization 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439401/
https://ncbi.nlm.nih.gov/pubmed/30937137
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2019.100011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados